BRAIN Biotech AG (LON:0RFI)
London · Delayed Price · Currency is GBP · Price in EUR 2.300
-0.040 (-1.71%)
At close: Sep 17, 2025
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of 41.31 million as of September 18, 2025. Its market cap has increased by 41.12% in one year.
Market Cap
41.31M
Enterprise Value
32.18M
Revenue
45.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 116.58M to 41.31M, a decrease of -64.56%. That is a compound annual growth rate of -10.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 41.31M | -35.76% |
| Dec 30, 2024 | 64.31M | -7.32% |
| Dec 29, 2023 | 69.39M | -38.69% |
| Dec 30, 2022 | 113.17M | -33.61% |
| Dec 30, 2021 | 170.45M | 5.04% |
| Dec 30, 2020 | 162.28M | -2.55% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| HSBC Holdings | 174.93B |
| Shell | 151.87B |
| Unilever | 113.50B |
| Rolls-Royce Holdings | 93.70B |
| British American Tobacco p.l.c. | 89.39B |
| Rio Tinto Group | 78.88B |
| BP p.l.c. | 64.72B |